Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 4
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean david bockel (22 results)?
Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression.
Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Böckle D, Rasche L, Martin Kortüm K, Lutz MB, Einsele H, Brandl A, Beilhack A. Dahlhoff J, et al. Among authors: bockle d. Leukemia. 2022 Mar;36(3):790-800. doi: 10.1038/s41375-021-01422-y. Epub 2021 Sep 28. Leukemia. 2022. PMID: 34584204 Free PMC article.
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma.
Böckle D, Tabares P, Zhou X, Schimanski S, Steinhardt MJ, Bittrich M, Seebacher E, Ulbrich M, Wilnit A, Metz C, Heidemeier A, Bley T, Werner R, Buck A, Einsele H, Kortüm KM, Beilhack A, Rasche L. Böckle D, et al. Br J Haematol. 2022 Aug;198(3):515-522. doi: 10.1111/bjh.18249. Epub 2022 May 18. Br J Haematol. 2022. PMID: 35582835
18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features.
Zhou X, Dierks A, Kertels O, Kircher M, Schirbel A, Samnick S, Buck AK, Knorz S, Böckle D, Scheller L, Messerschmidt J, Barakat M, Kortüm KM, Rasche L, Einsele H, Lapa C. Zhou X, et al. Among authors: bockle d. Cancers (Basel). 2020 Aug 18;12(8):2333. doi: 10.3390/cancers12082333. Cancers (Basel). 2020. PMID: 32824832 Free PMC article.
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma.
Steinhardt MJ, Zhou X, Krummenast F, Meckel K, Nickel K, Böckle D, Messerschmidt J, Knorz S, Dierks A, Heidemeier A, Lapa C, Einsele H, Rasche L, Kortüm KM. Steinhardt MJ, et al. Among authors: bockle d. Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420980258. doi: 10.1177/2058738420980258. Int J Immunopathol Pharmacol. 2020. PMID: 33353443 Free PMC article.
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CT.
Zhou X, Dierks A, Kertels O, Samnick S, Kircher M, Buck AK, Haertle L, Knorz S, Böckle D, Scheller L, Messerschmidt J, Barakat M, Truger M, Haferlach C, Einsele H, Rasche L, Kortüm KM, Lapa C. Zhou X, et al. Among authors: bockle d. Cancers (Basel). 2020 Aug 24;12(9):2399. doi: 10.3390/cancers12092399. Cancers (Basel). 2020. PMID: 32847053 Free PMC article.